Acessibilidade / Reportar erro

Indeterminate leprosy and lepromatous index case: four cases in the same family* * Work conducted at the University Hospital of the Federal University of Santa Catarina (Universidade Federal de Santa Catarina - UFSC) - Florianópolis (SC), Brazil.

Hanseníase indeterminada e caso índice virchowiano: 4 casos na mesma família

Abstracts

Leprosy is a chronic infectious disease caused by Mycobacterium leprae, which primarily affects the skin and peripheral nerves. Brazil remains as the country with the second largest number of cases in the world. We report the case of three patients diagnosed with indeterminate leprosy in the same family. Two patients were HIV positive. An active search led to the discovery of the index case. It was crucial to persist in the search of the index case. This report shows how important it is to teach physicians and the general population about the signs and symptoms of leprosy. Early diagnosis and treatment are necessary to prevent sequelae and to eliminate the disease as a public health problem.

HIV; Leprosy; Leprosy, lepromatous; Leprosy, paucibacillary


A hanseníase é uma doença infecciosa crônica causada pelo Mycobacterium leprae, que afeta principalmente a pele e nervos periféricos. O Brasil continua sendo o segundo país do mundo com maior número de casos. Aqui relatamos três pacientes diagnosticados com hanseníase indeterminada, pertencentes à mesma família, cuja busca ativa levou à descoberta do caso índice. Dois pacientes eram HIV positivos. Foi de imensa importância a insistência na procura pelo caso índice. Este relato ilustra a importância do ensino sobre sinais e sintomas de hanseníase na formação médica e à população. O pronto reconhecimento e tratamento são necessários para prevenir sequelas e eliminar a doença como problema de saúde pública.

Hanseníase; Hanseníase Paucibacilar; Hanseníase Virchowiana; HIV


INTRODUCTION

Leprosy is a chronic granulomatous infectious disease caused by the obligate intracellular bacillus Mycobacterium leprae. It primarily affects the skin and peripheral nerves.11. Walker SL, Lockwood DN. The clinical and immunological features of leprosy. Br Med Bull. 2006;77-78:103-21.,22. Ramos-e-Silva M, Rebello PF. Leprosy. Recognition and treatment. Am J Clin Dermatol. 2001;2:203-11. It is endemic in many regions of the world, and Brazil remains the country with the second largest number of cases.33. Sampaio S, Rivitti EA. Dermatologia. 2. ed. São Paulo: Artes Médicas; 2001. Over time, the manifestations of the disease cause deformities and mutilations, which are responsible for the stigma of the disease. The gram-positive, acid-fast bacillus44. Araújo MG. Hanseníase no Brasil. Rev Soc Bras Med Trop. 2003;36:373-82. was first described by GH Armauer Hansen in 1873.

We report the case of three patients diagnosed with Indeterminate Leprosy in the same family. An active search led to the discovery of the index case.

CASE REPORT

Patient A was 8 years old, female, and HIV +. She was using no medications and presented a single hypochromic lesion on the left forearm. Biopsy of the lesion was compatible with indeterminate leprosy (Figure 1). During the child's consultation, the mother (patient B), who was 34 years old, had been HIV + for 8 years and on antiretroviral therapy for 7, complained of a macule on the left arm which had appeared about 1 year earlier and which had started to show elevated borders 1 month before the consultation, with reduction of thermal sensitivity (Figure 2). On the next consultation, the mother brought another daughter (patient C), who was 19 years old and presented a hypochromic macula with reduced thermal sensitivity in the lateral region of the right knee (Figure 3). Biopsies of lesions from patients B and C were also compatible with indeterminate leprosy. There was no thickening of nerves in patients A, B or C. The three patients were diagnosed with indeterminate leprosy, and paucibacillary-multidrug therapy was started. We did not perform the Mitsuda test because it was not available in our service.

FIGURE 1
Patient A: HIV-positive, eight year-old girl presenting a hypochromic macula on the left arm
FIGURE 2
Patient B: HIV-positive, 34 year-old woman, patient A's mother, presenting hypochromic macula on the left arm
FIGURE 3
Patient C: HIV-negative, 19- year-old girl, patient A's sister, presenting hypochromic macula on the left thigh

Considering the 3 cases, we sought to identify a possible source of infection among close family members. The patients initially denied knowing about anyone close who had skin lesions. When we showed them a photo of a lepromatous patient in a book, the patients reported on a relative who presented similar lesions. Patient D, who is male, patient B's brother and patients A and C's uncle, was then brought by the family. He presented weakness and numbness in both hands, in addition to nasal obstruction. On examination, he showed nodules and tubercles on the face and pinnas, bilateral madarosis, diffuse infiltration in the trunk and lower limbs (Figure 4). There was cubital and auricular nerve thickening, which occurred bilaterally. There was hypoesthesia in bilateral legs and feet, hypoesthesia of the whole left arm and right arm (Figure 5). Skin smears were positive. Multibacillary multidrug therapy was initiated.

FIGURE 4
Patient D (index case): HIV-negative, 25-year-old man, patients A and C's uncle and patient B's brother, presenting nodles and tubercles, madarosis, and diffuse infiltration in the face
FIGURE 5
Patient D (index case): 25 years old, presenting thickening of the left auricular nerve and nodules and infiltration in the earlobe

The four patients are from Laguna, Santa Catarina. Patients A, B and C live in the same house. Patient D lives close, on the same street, and often visits the other patients. Four people were considered close contacts of the patients. These contacts did not want to be examined in our service, so they were advised to seek examination in the health center of their city of origin. Patients A and B completed treatment and were discharged as cured, presenting the characteristics they showed on the first physical examination. Patients C and D received 5 doses and asked to finish the treatment in their hometown. The cases were then transferred.

DISCUSSION

The transmission of leprosy occurs from individual to individual, between lepromatous and borderline patients and healthy individuals. Higher risks are associated with living in the same place as an untreated patient positive for acid-fast bacilli.11. Walker SL, Lockwood DN. The clinical and immunological features of leprosy. Br Med Bull. 2006;77-78:103-21.,44. Araújo MG. Hanseníase no Brasil. Rev Soc Bras Med Trop. 2003;36:373-82. The routes of elimination of the microorganism are mainly the upper airway and lesioned areas of the skin.44. Araújo MG. Hanseníase no Brasil. Rev Soc Bras Med Trop. 2003;36:373-82. The bacillus is highly infectious, but presents low pathogenicity and virulence, that is, many people are infected, but few get sick.44. Araújo MG. Hanseníase no Brasil. Rev Soc Bras Med Trop. 2003;36:373-82. The rate at which leprosy spreads depends on the susceptibility of the individual and the opportunity of contact with the microorganism.55. Mehta V, Vasanth V, Balachandran C. Conjugal leprosy: A rarity. Dermatol Online J. 2010;16:15. The host's innate response is what determines the clinical manifestation of the disease.11. Walker SL, Lockwood DN. The clinical and immunological features of leprosy. Br Med Bull. 2006;77-78:103-21. Contact with infected patients does not always result in transmission of the disease, and different individuals exposed to the same infected case develop different clinical forms.55. Mehta V, Vasanth V, Balachandran C. Conjugal leprosy: A rarity. Dermatol Online J. 2010;16:15.

The World Health Organization classifies patients into paucibacillary, if they have five or fewer skin lesions, and multibacillary, if they have six or more skin lesions or if the skin smear is positive. The Ridley-Jopling classification subdivides leprosy into the following clinical forms: indeterminate, tuberculoid, borderline-tuberculoid, borderline-borderline, borderline-lepromatous and lepromatous.22. Ramos-e-Silva M, Rebello PF. Leprosy. Recognition and treatment. Am J Clin Dermatol. 2001;2:203-11.,66. Ridley DS, Jopling WH. Classification of leprosy according to immunity. A five-group system. Int J Lepr Other Mycobact Dis.1966;34:255-73. In relation to risk factors for leprosy, close contacts of an infected individual have a greater chance of acquiring the disease in comparison with the general population.77. Moet FJ, Pahan D, Schuring RP, Oskam L, Richardus JH. Physical distance, genetic relationship, age, and leprosy classification are independent risk factors for leprosy in contacts of patients with leprosy. J InfectDis. 2006;193:346-53. In 2006, Moet et al. observed in their work that individuals in contact with leprosy patients aged 5-9 years and older than 30 have a higher risk of acquiring the disease. Those aged between 20-29 years are less likely to acquire it.77. Moet FJ, Pahan D, Schuring RP, Oskam L, Richardus JH. Physical distance, genetic relationship, age, and leprosy classification are independent risk factors for leprosy in contacts of patients with leprosy. J InfectDis. 2006;193:346-53. Also, those in contact with multibacillary patients are at greater risk of developing the disease. The risk should be higher among relatives, even when they are not close contacts, due to genetic influences.77. Moet FJ, Pahan D, Schuring RP, Oskam L, Richardus JH. Physical distance, genetic relationship, age, and leprosy classification are independent risk factors for leprosy in contacts of patients with leprosy. J InfectDis. 2006;193:346-53.,88. Durães SM, Guedes LS, Cunha MD, Magnanini MM, Oliveira ML.Epidemiologic study of 107 cases of families with leprosy in Duque de Caxias, Rio de Janeiro, Brazil. An Bras Dermatol. 2010;85:339-45.

There is a correlation between cases of multi-bacillary leprosy in children, the endemic situation of the country, and late diagnosis. The disease is mainly transmitted to children through close family contacts. The younger the child, the greater the number of infected individuals found among the family members.99. Barbieri CLA, Marques HHS. Hanseníase em crianças e adolescentes:revisão bibliográfica e situação atual no Brasil. Pediatria (São Paulo). 2009;31:281-90. Barbieri's study shows that the most affected age group among children is between 10 and 15 years, with prevalence increasing as the age increases.99. Barbieri CLA, Marques HHS. Hanseníase em crianças e adolescentes:revisão bibliográfica e situação atual no Brasil. Pediatria (São Paulo). 2009;31:281-90.

Every hypochromic lesion in children living in an endemic area should raise the suspicion of leprosy.99. Barbieri CLA, Marques HHS. Hanseníase em crianças e adolescentes:revisão bibliográfica e situação atual no Brasil. Pediatria (São Paulo). 2009;31:281-90. Most children have lesions on exposed areas such as the trunk and limbs. In Brazil, the high prevalence of leprosy leads children to have contact with the disease. In case of suspicion, a thorough medical history should be done, with an investigation of the clinical and epidemiological history, as well as a detailed dermato-neurological examination.99. Barbieri CLA, Marques HHS. Hanseníase em crianças e adolescentes:revisão bibliográfica e situação atual no Brasil. Pediatria (São Paulo). 2009;31:281-90.

Regarding a leprosy and HIV coinfection, the difficulty in conducting prospective studies due to the long incubation period of M. leprae makes it impossible to confirm whether HIV-positive patients are more likely to develop leprosy than HIV-negative patients.1010. Ustianowski AP, Lawn SD, Lockwood DN. Interactions between HIV infection and leprosy: a paradox. Lancet Infect Dis. 2006;6:350-60. The clinical spectrum seems to remain unchanged, as well as the adverse effects of multidrug therapy.44. Araújo MG. Hanseníase no Brasil. Rev Soc Bras Med Trop. 2003;36:373-82.

As demonstrated by the cases here presented, persisting in the search for the index case was of paramount importance. They show how important it is to teach physicians and the general population about the signs and symptoms of leprosy. Prompt recognition and treatment are necessary to prevent sequelae and eliminate the disease as a public health problem.

REFERENCES

  • 1
    Walker SL, Lockwood DN. The clinical and immunological features of leprosy. Br Med Bull. 2006;77-78:103-21.
  • 2
    Ramos-e-Silva M, Rebello PF. Leprosy. Recognition and treatment. Am J Clin Dermatol. 2001;2:203-11.
  • 3
    Sampaio S, Rivitti EA. Dermatologia. 2. ed. São Paulo: Artes Médicas; 2001.
  • 4
    Araújo MG. Hanseníase no Brasil. Rev Soc Bras Med Trop. 2003;36:373-82.
  • 5
    Mehta V, Vasanth V, Balachandran C. Conjugal leprosy: A rarity. Dermatol Online J. 2010;16:15.
  • 6
    Ridley DS, Jopling WH. Classification of leprosy according to immunity. A five-group system. Int J Lepr Other Mycobact Dis.1966;34:255-73.
  • 7
    Moet FJ, Pahan D, Schuring RP, Oskam L, Richardus JH. Physical distance, genetic relationship, age, and leprosy classification are independent risk factors for leprosy in contacts of patients with leprosy. J InfectDis. 2006;193:346-53.
  • 8
    Durães SM, Guedes LS, Cunha MD, Magnanini MM, Oliveira ML.Epidemiologic study of 107 cases of families with leprosy in Duque de Caxias, Rio de Janeiro, Brazil. An Bras Dermatol. 2010;85:339-45.
  • 9
    Barbieri CLA, Marques HHS. Hanseníase em crianças e adolescentes:revisão bibliográfica e situação atual no Brasil. Pediatria (São Paulo). 2009;31:281-90.
  • 10
    Ustianowski AP, Lawn SD, Lockwood DN. Interactions between HIV infection and leprosy: a paradox. Lancet Infect Dis. 2006;6:350-60.
  • * Work conducted at the University Hospital of the Federal University of Santa Catarina (Universidade Federal de Santa Catarina - UFSC) - Florianópolis (SC), Brazil.
  • Conflict of interest: None
  • Financial Support: None

Publication Dates

  • Publication in this collection
    Nov-Dec 2013

History

  • Received
    06 Aug 2012
  • Accepted
    06 Nov 2012
Sociedade Brasileira de Dermatologia Av. Rio Branco, 39 18. and., 20090-003 Rio de Janeiro RJ, Tel./Fax: +55 21 2253-6747 - Rio de Janeiro - RJ - Brazil
E-mail: revista@sbd.org.br